UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Apr

    27

    Voices on Value: Breaking Down the Value Chain: The Policies Impacting Patients

    Read More Share:linkedin| twitter| email

    Apr

    26

    Employee Spotlight: Debbie Smith’s Journey on Moving the Conversation Forward in Epilepsy and Health Equity

    Read More Share:linkedin| twitter| email

    Apr

    21

    Earth Day 2023: Our Commitment to Sustainability in the Workplace

    Read More Share:linkedin| twitter| email

    Apr

    20

    UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting

    Read More Share:linkedin| twitter| email

    Apr

    18

    How Shared Decision-Making Creates Better Patient-Provider Collaboration in Dermatology

    Read More Share:linkedin| twitter| email

    Apr

    17

    UCB Announces FINTEPLA® (fenfluramine) Oral Solution Is Now Descheduled and Is No Longer Listed as a Controlled Substance

    Read More Share:linkedin| twitter| email

    Apr

    14

    Recognizing UCB’s Rising Stars: Brittany Blair and Lauren Drowley Recognized by the Healthcare Businesswomen’s Association

    Read More Share:linkedin| twitter| email

    Apr

    13

    UCB’s Commitment to Understanding Sudden Unexpected Death in Epilepsy (SUDEP)

    Read More Share:linkedin| twitter| email

    © 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
    USPR-CORP-0115-00003(2)